Tag Archives: STJ

Top 10 High Tech Stocks To Invest In Right Now

Shutterstock

Today I’m going to show you, hands-down, the easiest way to add rental real estate to your portfolio.

Don’t worry—you won’t have to leave your computer! Instead of hitting the streets to buy a four-plex or apartment building to rent out, we’re going to purchase a recession-proof real estate income stream straight from your online brokerage account.

And believe it or not, thanks to a current market anomaly, we can snag better deals online right now than we can in person. I’ll explain the details in a moment—including 2 stocks with yields that double what your average stock pays, and double-digit payout growth, too!

First, let me give you the lay of the residential real estate landscape.

A Bait-and-Switch Market

As I write, apartment vacancy rates across the US are tight—sitting at 6.9%, the lowest level in 24 years!

Top 10 High Tech Stocks To Invest In Right Now: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

Top 10 High Tech Stocks To Invest In Right Now: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Qualstar Corporation (NASDAQ: QBAK) was down, falling around 16 percent to $6.99. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.

Top 10 High Tech Stocks To Invest In Right Now: AFC Enterprises Inc.(AFCE)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    AFC Enterprises (NASDAQ: AFCE  ) , which owns the Popeye’s Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.

Top 10 High Tech Stocks To Invest In Right Now: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Biogen (BIIB) tumbled to the bottom of the S&P 500 today after getting cut by two analysts.

    Agence France-Presse/Getty Images

    Biogen dropped 4.7% to $278.96 at 4:19 p.m. today, while the S&P 500 declined 0.2% to 2,381.38.

    Leerinks Geoffrey Porges cited the “slower than expected ramp for Spinraza” in cutting Biogen to Market Perform from Outperform, while Morgan Stanly’s Matthew Harrison wrote that his decision to cut Biogen to Market Weight from Overweight was “not a downside call, but a timing call.”

    Biogen’s market capitalization fell to $60.2 billion today from $63.2 billion yesterday. It reported net income of $3.7 billion on sales of $10.2 billion in 2016.

    Barron’s Teresa Rivas recommended buying Biogen in December after the company released positive trial data on its Alzheimer’s drug.

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Biogen Inc. (NASDAQ: BIIB) which traded down 4.6% at $279.08. The stocks 52-week range is $223.02 to $333.65. Volume was 3.4 million versus the daily average of 1.6 million shares.

Top 10 High Tech Stocks To Invest In Right Now: Flowserve Corporation(FLS)

Advisors’ Opinion:

  • [By Damon Churchwell]

    Increasing sales and margins
    A second, even larger, flow technology company to consider is Flowserve (NYSE: FLS  ) . The company’s flow control systems are utilized by a wide range of industries, led by oil & gas, chemicals, and power generation.

Top 10 High Tech Stocks To Invest In Right Now: ADDvantage Technologies Group, Inc.(AEY)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedshorting small cap cable television and telecommunications equipment stock ADDvantage Technologies Group, Inc (NASDAQ: AEY):

Top 10 High Tech Stocks To Invest In Right Now: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 High Tech Stocks To Invest In Right Now: China Jo-Jo Drugstores, Inc.(CJJD)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap Chinese retail pharmacy stock China Jo-Jo Drugstores (NASDAQ: CJJD) as a bullish long trade:

Top 10 High Tech Stocks To Invest In Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Top 10 High Tech Stocks To Invest In Right Now: BIG YELLOW GROUP PLC (BYLOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The Big Yellow Group (OTC:BYLOF) recognized this opportunity back in 1998 when it was founded and has ever since been working towards bringing new supply of self-storage properties to the UK market. The strategy resulted in the following performance:

Best Energy Stocks To Invest In Right Now

San Francisco, CA, based Investment company Dodge & Cox buys Express Scripts Holding Co, Suncor Energy Inc, Bristol-Myers Squibb Company, Juniper Networks Inc, UBS Group AG, Cemex SAB de CV, News Corp, America Movil SAB de CV, sells Royal Dutch Shell PLC, NetApp Inc, Adient PLC, Symantec Corp, Unilever PLC during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Dodge & Cox. As of 2017-03-31, Dodge & Cox owns 179 stocks with a total value of $117.7 billion. These are the details of the buys and sells.

Added Positions: ESRX, SU, NVS, BMY, JNPR, UBS, AZN, CX, MDT, GOOG, Reduced Positions: SLB, RDS.A, HPQ, NTAP, BK, ADNT, SYMC, DVMT, BHI, GLW, Sold Out: HES, LOGM, LOW, MS,

For the details of Dodge & Cox’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Dodge+%26+Cox

These are the top 5 holdings of Dodge & CoxBank of America Corporation (BAC) – 185,448,539 shares, 3.72% of the total portfolio. Shares reduced by 1.47%Wells Fargo & Co (WFC) – 71,190,652 shares, 3.37% of the total portfolio. Shares reduced by 0.48%Charles Schwab Corp (SCHW) – 95,552,125 shares, 3.31% of the total portfolio. Shares reduced by 1.11%Capital One Financial Corp (COF) – 44,582,892 shares, 3.28% of the total portfolio. Shares reduced by 1.39%Novartis AG (NVS) – 50,585,790 shares, 3.19% of the total portfolio. Shares added by 10.65%Added: Express Scripts Holding Co (ESRX)

Dodge & Cox added to their holdings in Express Scripts Holding Co by 35.99%. Their purchase prices were between $63.84 and $73.16, with an estimated average price of $68.81. The stock is now traded at around $62.47. The impact to their portfolio due to this purchase was 0.43%. Their holdings were 28,800,496 shares as of 2017-03-31.

Best Energy Stocks To Invest In Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Best Energy Stocks To Invest In Right Now: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:

Best Energy Stocks To Invest In Right Now: QC Holdings Inc.(QCCO)

Advisors’ Opinion:

  • [By Monica Gerson]

    QC Holdings (NASDAQ: QCCO) shares tumbled 2.58% to reach a new 52-week low of $2.27. QC Holdings’ trailing-twelve-month profit margin is 0.60%.

    NewLead Holdings (NASDAQ: NEWL) shares dipped 6.56% to touch a new 52-week low of $0.08 after the company completed the acquisition of titles in the Viking Mine located in Kentucky, USA.

Top Growth Stocks To Own For 2018

Meir Statman: What Normal People Really Want From Advisors

Kansas Judge Upholds DOL Fiduciary Rule

6 Tax-Law Time Bombs Affecting IRAs

T. Rowe Price expects a slight improvement in the global economic environment in 2017 helped by the growth rebound in the U.S., Canada, Brazil and Russia – but deleveraging and restructuring headwinds persist.

“Economic growth has improved in the second half of 2016 as the impact of the commodity price plunge fades,” according to Alan Levenson, chief U.S. economist at T. Rowe Price.

Financial advisors favored Trump over Clinton by a ratio of more than 3 to 1, according to a post-elction poll…

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources Nine Reasons for Becoming a Fee-Based Advisor

Consider the benefits of converting to a fee-based model, along with comparing it to a commission structure.

Top Growth Stocks To Own For 2018: Bunge Limited(BG)

Advisors’ Opinion:

  • [By Casey Wilson]

    Many companies provide the infrastructure needed for farmers to move crops from the farm to the grocery store. Among those are Bunge Ltd. (NYSE: BG), an agribusiness and food company that specializes in the purchase, storage, processing, and transport of agricultural goods. BG is up over 8% year to date and has grown over 1.5% in the past 30 days.

  • [By Steve Symington]

    Shares ofBunge Ltd.(NYSE:BG)rose 10% on Wednesday after the agribusiness and food company released strong fourth-quarter 2016 results.

    So what

    Quarterly revenue grew 8.6% year over year, to $12.1 billion, and translated to 14.1% growth in adjusted earnings per share, to $1.70. Analysts, on average, were only expecting Bunge to report revenue of $11.4 billion and adjusted earnings of $1.57 per share.

  • [By Ben Levisohn]

    Bunge (BG) has dropped 1.5% to $76.14 after getting cut to Underweight from Neutral at JPMorgan.

    L Brands (LB) has jumped 3.9% to $44.80 despite reporting weaker than expected same-store sales.

Top Growth Stocks To Own For 2018: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

Top Growth Stocks To Own For 2018: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Top 10 Undervalued Stocks To Buy Right Now

The Economist has a nice piece which highlights the fundamental conflict at the heart of Bitcoin. Miners want the price of bitcoin to keep on rising, because this gives them an incentive to keep mining despite the ever-rising energy cost of doing so. Users, however, want liquidity. They want transactions settled quickly and efficiently, at low cost.

Why is this a conflict, you ask? Simple. It is in the miners’ interests to restrict liquidity in the system, because doing so raises their returns. Liquidity is undervalued in the Bitcoin system – hence the hard cap on issuance and designed-in capacity limitations. So there is a clear incentive to hoard. Keeping bitcoins out of circulation pushes up the price at the expense of liquidity, which pleases the miners at the expense of the users.

Shutterstock

Top 10 Undervalued Stocks To Buy Right Now: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Chris Lange]

    B&G Foods Inc. (NYSE: BGS) madewaves late on Friday after the company announced its most recent acquisition. B&G has now acquired Victoria Fine Foods from Huron Capital Partners and other sellers for roughly $70 million in cash.

Top 10 Undervalued Stocks To Buy Right Now: American Capital, Ltd.(ACAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    American Capital Ltd. (NASDAQ: ACAS) shares rose 5.63 percent to $16.50 in the pre-market trading session as Ares Capital Corporation (NASDAQ: ARCC) reported the purchase of American Capital at $3.4 billion in cash and stock.

Top 10 Undervalued Stocks To Buy Right Now: TransAlta Renewables Inc. (TRSWF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    TransAlta Renewables (OTC:TRSWF) (RNW CA) is a good comp, and trades at 12.3x EBITDA. Similar to NYLD, they own renewables as well as a few gas-fired power plants. The yield on RNW is similar to NYLD at 6.0%. The only real difference is that RNW is less levered (mid-3s on a debt/EBITDA basis), but has clearly overpaid for certain assets in order to help the parent (TransAlta Corp. ticker TA in Canada) to delever.

Top 10 Undervalued Stocks To Buy Right Now: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Casey Wilson]

    Take general contracting company Tutor Perini (NYSE: TPC), for example.

    The California-based contracting giant is responsible for funding many infrastructure projects, including “Big Bertha,” a huge tunnel-boring project in Seattle, Wash. This tunnel will be 9,270 feet long and 115 feet deep – allowing for a major highway to be carried under downtown Seattle.

Top 10 Undervalued Stocks To Buy Right Now: DAVIDsTEA Inc.(DTEA)

Advisors’ Opinion:

  • [By Monica Gerson]

    DavidsTea Inc (NASDAQ: DTEA) is expected to post its quarterly earnings at $0.43 per share on revenue of $71.74 million.

    SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.

Top 10 Undervalued Stocks To Buy Right Now: InterCloud Systems, Inc(ICLD)

Advisors’ Opinion:

  • [By Monica Gerson]

    InterCloud Systems Inc (NASDAQ: ICLD) is expected to post a quarterly loss at $0.14 per share on revenue of $24.00 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Undervalued Stocks To Buy Right Now: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Top 10 Undervalued Stocks To Buy Right Now: Farmer Brothers Company(FARM)

Advisors’ Opinion:

  • [By Matt Hogan]

    Finbox.io fair value data (as of January 4) shows that there are only five US manufacturing stocks that have 25% or more margin of safety: Vera Bradley, Inc. (NASDAQ: VRA), Cooper Tire & Rubber Co (NYSE: CTB), Farmer Brothers Co. (NASDAQ: FARM), Allergan plc Ordinary Shares (NYSE: AGN) and Motorcar Parts of America, Inc. (NASDAQ: MPAA).

Top 10 Undervalued Stocks To Buy Right Now: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares climbed by 1.52 percent in trading on Friday. Meanwhile, top gainers in the sector included Companhia Siderurgica Nacional (ADR) (NYSE: SID), and Core Molding Technologies, Inc. (NYSE: CMT).

Top 10 Undervalued Stocks To Buy Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Top 10 Low Price Stocks To Buy Right Now

When fear and volatility rear their ugly heads, investors will traditionally turn to more conservative investments — such as gold. Presumably, this is what happened during the bitterly fought presidential campaign. In 2016, the price of gold, which ended the year up about 8%, had climbed as much as 28% at one point.

Similarly, many gold stocks enjoyed quite the ride last year — rides that have extended into the new year, leaving some companies trading at seriously low prices. Of course, this doesn’t mean these companies are worthy of investment. So let’s grab our pickaxes and see what we can uncover.

Image source: Getty Images.

Minding the miners

When considering gold-mining companies’ stocks, it’s important to recognize that the traditional price-to-earnings ratio doesn’t have as much merit. Because of non-cash charges — like depreciation — it’s not uncommon for companies to take large writedowns on their assets, resulting in skewed earnings figures. Yamana Gold, for example,recorded non-cash impairment charges of $2.6 billion.In the company’s annual report, management acknowledged that “the largest contributor to the impairment was the writedown of values relating to exploration landand potential ounces.”

Top 10 Low Price Stocks To Buy Right Now: BlackBerry Limited(BBRY)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    BlackBerry (NASDAQ:BBRY) announced recently that it is “opening up some of its secure messaging and file sharing technology for developers to use in building apps, creating a new revenue stream for the company as it works to boost sales”. BlackBerry adds to Twilio’s existing competitorsBandwidth and Nexmo and it seeks to differentiate itself from others with its reputation for security and better offerings for enterprises. However, Twilio CEO Jeff Lawson wasvery sure of Twilio’s leadership position going ahead and this is what he stated in the earnings call when asked about BlackBerry’s entry:

  • [By Kumar Abhishek]

    Shares of Ontario-basedsoftware companyBlackBerry Ltd (NASDAQ:BBRY) jumped more than 16% in yesterday’s trade,creating a new 52-week highafter the company announced that it has won a windfall of $814.9 million in an interim arbitrationaward against Qualcomm (NASDAQ:QCOM).Moreover, the arbitration award is not appealable by Qualcomm. The final award which will include interest rates and legal fees will be decided on May 31st. The windfall gain has earned BBRY stock price target upgrades from several analysts. The arbitration relates to an overpayment of royalty by BlackBerry Ltd between 2010 and 2015. The question now is, does this one-time award change anything for BlackBerry Ltd stock?

  • [By Peter Graham]

    Mid cap mobile device and smartphone stock BlackBerry Ltd (NASDAQ: BBRY) has just reported earnings for Q4 and the fiscal year ended February 28, 2017 with shares rising by the low to mid single digits in pre-market trading. Q4 GAAP revenue fellto $286M from $464M a year ago and from$289M sequentially while the net loss fell to$47M from $117Ma year ago and$238M sequentially. For the full year, GAAP revenue was $1.309B versus$2.160B and the net loss was$1.206B versus$208M.

  • [By Sreekanth Anasa]

    Shares of San Diego, California-based QUALCOMM, Inc. (NASDAQ:QCOM)plunged further, losing more than 3.5% in yesterday’s trade. QCOM stock is now near its lowest levels since the post-earnings sell off. QCOM stock dipped on account of the smartphone chipmaker losing an arbitration case against BlackBerry (NASDAQ:BBRY). Qualcomm was ordered to refund a sum of nearly $815M to the software company. This comes on the back of the San Diego company’s latest countersuit againstApple (NASDAQ:AAPL). QCOM stock had already been battered this year on account of its mounting legal troubles. With Qualcomm stock trading at such low levels, investors could be puzzled about whether they should buy this dip in QCOM stock.Is QCOM stock headed much lower? Will Qualcomm stock rebound ahead of its earnings? Let’s take a closer look.

  • [By Kumar Abhishek]

    The Canadian software firm, BlackBerry (NSDQ:BBRY), is scheduled to release its Q3 2017 earnings report on Tuesday, 20th of December. This will be the first earnings since the company dumped its handset business and became a software company, one of the boldest move of its turnaround strategy. During the quarter, BlackBerry launched two handsets, DTEK50 and DTEK60 and entered into an agreement with Ford to expand the usage of its QNX software by providing a secure infotainment solution. BlackBerry is also making strong moves into MedTechcybersecurity.

  • [By Sreekanth Anasa]

    The mobile chip giant reported a YoY increase of 29% and 8% on EPS and revenues, respectively, for the second quarter. In Q2, Qualcomm saw its licensing business (QTL segment) deliver a revenue of $2.2B, a 5% YoY increase, which was in line with expectations. The licensing business did not take a hit in Q2 on account of the legal issues. The company’s technology division QCT performed better than expected with revenues increasing 10% from a year ago, to $3.7B. Qualcomm saw a strong performance this quarter, particularly in the automotive, networking and IoT areas. It is worth noting that the company’s GAAP results reflected aBlackBerry (NASDAQ:BBRY) arbitration reward of$974M which reduced fiscal second quarter GAAP EPS by approximately $0.48 per share. The smartphone chipmaker also recognized disputed revenue withheld by Apple’s(NASDAQ:AAPL)contract manufacturers. The above Apple suppliers reported disputed revenuefully in their books for Q2, but have underpaid and also not filed a formal dispute. So, Qualcomm decided to take the revenue for the amount paid while they continue to work on collecting the balance owed. It is only a matter of cash flow now.

Top 10 Low Price Stocks To Buy Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

Top 10 Low Price Stocks To Buy Right Now: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Southern Company (SO) produces 44,000 megawatts of generating capacity and 1,500 billion cubic feet of combined natural gas consumption and throughput volume.

  • [By Dustin Parrett]

    Natural gas just claimed another victory over clean coal, as Southern Co. (NYSE: SO) announced on June 28 it’s converting its failed $7.1 billion clean coal power plant into a natural gas-fired facility.

  • [By Dustin Parrett]

    Over seven years ago, Southern Co. (NYSE: SO) took a gamble on “clean coal” by building a state-of-the-art clean coal power plant in Kemper County, Miss. Clean coal plants were supposed to be a revolutionary way to burn coal with less pollution.

  • [By Ben Levisohn]

    For those that are looking to express a more downbeat market view, or looking for a source of funds, we can neutralize our positive S&P 500 outlook and aim to sell stocks that are at risk to underperform on a relative basis. While a rising tide lifts all boats in absolute terms, we found that mega-cap safety is the central theme linking stocks that are at, or nearing, decade-long relative lows vs. the S&P 500: General Electric, Southern (SO), Simon Property Group (SPG), Verizon Communications (VZ), Wal-Mart, ExxonMobil. We see such relative weakness as a sign of vulnerability in their trend.

Top 10 Low Price Stocks To Buy Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Emily Stewart]

    Paulson picked up 45,500 shares of St. Jude Medical (STJ) . The stake is worth $3.5 million as of the end of the second quarter.

    St. Jude Medical develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. It has a $23.6 billion market cap and trades at a P/E of 36.03. 

Top 10 Low Price Stocks To Buy Right Now: Visa Inc.(V)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Visa Inc. (NYSE:V) and MasterCard (NYSE:MA) aren’t the only two players in the credit card and electronic payments space, but they are the biggest and best-known. Both Visa and MasterCard have extended their reach across the globe, and both have high expectations in their trajectories for future growth. Yet after a big push in the stock market that has sent both of these financial stocks to all-time highs, investors need to know which of the two leaders in the card industry is more deserving of their attention. Let’s take a closer look at Visa and MasterCard, comparing them using several different metrics to see which company’s shares are the better buy.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Honeywell International Inc. (NYSE: HON) to report quarterly earnings at $1.60 per share on revenue of $9.32 billion before the opening bell. Honeywell shares gained 0.11 percent to $123.91 in after-hours trading. Analysts expect General Electric Company (NYSE: GE) to report quarterly earnings at $0.17 per share on revenue of $26.46 billion before the opening bell. General Electric shares gained 1.06 percent to $30.59 in after-hours trading. Mattel, Inc. (NASDAQ: MAT) reported weaker-than-expected results for its first quarter on Thursday. Mattel shares dropped 6.78 percent to $23.50 in the after-hours trading session. Before the opening bell, Stanley Black & Decker, Inc. (NYSE: SWK) is estimated to report quarterly earnings at $1.19 per share on revenue of $2.74 billion. Stanley Black & Decker shares declined 0.01 percent to $132.70 in after-hours trading. Visa Inc (NYSE: V) posted stronger-than-expected results for its first quarter on Thursday. Visa shares rose 2.35 percent to $93.29 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Brian Feroldi, Dan Caplinger, Travis Hoium, and Matthew DiLallo]

    While we Fools are generally bargain hunters, we recognize that some companies are so fantastic that it can make sense to buy them while they’re on the upswing. With that in mind, we asked a team of Fools to each highlight a stock trading near its 52-week that is still worth buying today. Read on to see why they selected Visa (NYSE:V), Brookfield Infrastructure Partners (NYSE:BIP), Paycom Software (NYSE:PAYC), and Apple (NASDAQ:AAPL).

Top 10 Low Price Stocks To Buy Right Now: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Endologix Inc. (NASDAQ: ELGX) dropped about 9.3% on Wednesday to post a new 52-week low of $4.78 against a 52-week high of $14.50 and a Tuesday close of $5.27. Volume of about 6 million was more than 3 times the daily average of around 1.7 million. The company on Tuesday announced a temporary shipping hold on its best-selling heart device, saying there was a manufacturing issue.

  • [By Lisa Levin]

    Endologix, Inc. (NASDAQ: ELGX) shares dropped 23 percent to $7.59 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.

Top 10 Low Price Stocks To Buy Right Now: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

Top 10 Low Price Stocks To Buy Right Now: Corcept Therapeutics Incorporated(CORT)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week:Corcept Therapeutics Inc. (NASDAQ: CORT), Customers Bancorp Inc. (NYSE: CUBI), Ellie Mae Inc. (NYSE: ELLI), Fiserv Inc. (NASDAQ: FISV) and Ulta Beauty Inc. (NASDAQ: ULTA).

Top 10 Low Price Stocks To Buy Right Now: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading. Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading. Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session. Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading. Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session. Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Wayne Duggan]

    According to Deutsche Bank analyst Carlo Santarelli, news that Las Vegas Sands Corp. (NYSE: LVS) may be selling its Sands Bethlehem resort to MGM Resorts International (NYSE: MGM) could be a win-win-win for Sands, MGM and MGM Growth Properties LLC (NYSE: MGP).

  • [By Travis Hoium]

    MGM Resorts (NYSE:MGM) has also taken a fairly aggressive approach to Japan, releasing renderings of what its casino might look like in Osaka. And given the company’s renewed financial health, it’s possible it would be a good bet to win a gaming concession.

Top 10 Low Price Stocks To Buy Right Now: ImmunoCellular Therapeutics, Ltd.(IMUC)

Advisors’ Opinion:

  • [By Paul Ausick]

    ImmunoCellular Therapeutics Ltd. (NYSEMKT: IMUC) posted a new 52-week low of $0.48 on Tuesday, down nearly 61% compared with Monday’s closing price of $1.22. Volume totaled around 7.3 million shares, nearly 25 times the daily average. The company had no specific news Tuesday. The company price an offering of 5,000 preferred stock and warrants to purchase another 9,000 shares of preferred stock a $1,000 per share to raise approximately $5 million.